bridge4

Clinical Pharmacology of Miami

Miami Lakes, FL

 

CPMI Overview

Follow Us On Social Media:
Facebook
Twitter

Principal Investigators

  • Kenneth C. Lasseter, MD
    Board Certified Cardiology & Internal Medicine

Site Contact
Stacy C. Dilzer, R.N., B.S.N.

Specialties

  • Complex Early Phase Inpatient Trials
  • Hepatic & Renal Impairment
  • Diabetic Type 2
  • Sexual Dysfunction
  • First-In-Man Studies

Facility

  • 24,000 Square Foot Inpatient & Outpatient Unit
  • 120 Research Beds
  • Secure, Alarm-Monitored Pharmacy Department and Double-Locked Drug Storage Room
  • Environmental Monitoring System
  • Large, Secure PK Processing Lab
  • -20 to -70 Degree Sample Storage
  • QTc Clinical Trial ECG Monitored Research Areas
  • 24 Hour CCTV Recording
  • 40-Watt Natural Gas Generator

Institutional Review Board
Central

Contact
info@cnssites.com
+1-908-756-4411

Staffing
40
Staff Members
  • 5 Sub-Investigators
  • 6 RNs/Nurse Practitioners
  • 8 CRCs
  • 1 Pharmacist
  • 3 Recruitment Staff
Patient Database
5,000
Number of Subjects
  • 40 Renal
  • 45 Hepatic
  • 3,850 NHV
  • 500 Diabetic Type 2
  • 170 Healthy Geriatric
  • 120 Post Menopausal
  • 80 Hypertensive
  • 65 Obese
  • 70 Hypo Gonadal
  • 60 Hepatitis C
Study Experience
1,200
Total Studies
  • 33 Renal (last three years)
  • 32 Hepatic (last three years)
  • 42 DDI
  • 28 Diabetic
  • 16 SAD/MAD (last three years)
  • 22 BA/BE (last three years)
  • 24 QTc
  • 12 Inhalation
  • 26 Anticoagulant and Subcutaneous